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Endothelial Dysfunction in Healthy Passive Smoker
Badai Tiksnadi, Augustine Purnomowati, M. Rizki Akbar
Introduction. Passive smoking may have a deleterious effect to cardiovascular system and subsequent enormous public health implication. The sidestream cigarette smoke suggest impaired endothelial production of nitrit oxide. Since endothelial dysfunction is an early feature of atherogenesis, early detection on this become important and hopefully can prevents the subsequent atherosclerlotic events. There were only few studies have assessed the effects of passive smoking to human arterial wall. The objective of this study was to detect endothelial dysfunction in healthy passive smokers young adults.
Methods. We studied 80 healthy subjects 20 to 35 years old, which were divided into two groups, consist of 32 passive smokers and 48 subjects as controls. Passive smokers were defined as non-smokers who had been exposed to environmental tobacco smoke for at least one hour daily for three or more years. Endothelial function was measured by response of flow-mediated vasodilatation in brachial artery during reactive hyperemia.
Result. There are no significant differences in baseline characteristics (age, sex and baseline diameter) between two groups. Flow-mediated dilatation response was significantly impaired in the passive smokers 8.7 (2.9) percent compared with 12.8 (6.7) percent in control subject, p =0.006. 
Conclusion. Passive smoking is associated with impairment of endothelium-dependent dilatation, suggesting early event in atherosclerosis.
(J Kardiol Indones. 2012;33:149-57)
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Active cigarette smoking has long been known to 
predispose people to endothelial dysfunction that 
leads to atherosclerotic vascular disease. However it 
has recently became evident that passive smoking 
may also have a deleterious effect to cardiovascular 
system as well and subsequent enormous public health 
implication.1
Latar belakang. Merokok pasifdapat mempunyai efek yang merugikan terhadap sistem kardiovaskular dan berdampak besar bagi 
kesehatan masyarakat secara luas. Asap rokok diduga mengganggu produksi nitrit oksida di endotel. Karena disfungsi endotel 
adalah ciri awal dari proses aterogenesis, deteksi dini sangat diperlukan sehingga dapat dilakukan upaya-upaya pencegahan 
kejadian kardiovaskular dikemudian hari. Hingga saat ini hanya sedikit saja penelitian yang membahas mengenai efek merokok 
pasif terhadap dinding pembuluh darah arteri. Tujuan dilakukan penelitian ini adalah untuk mendeteksi disfungsi endotel dini 
pada perokok-perokok pasif, dewasa muda dan sehat. 
Metode. Kami meneliti pada sebanyak 80 subyek sehat berusia 20-35 tahun yang dibagi kedalam dua kelompok, terdiri dari 
32 perokok pasif, dan 48 subyek sebagai kontrol. Perokok pasif didefinisikan sebagai orang yang tidak merokok, yang terkena 
paparan asap tembakau minimal satu jam setiap harinya, selama minimal tiga tahun. Fungsi endotel diukur dengan melihat 
respon vasodilatasi termediasi oleh aliran (flow-mediated vasodilation) selama hiperemia reaktif. 
Hasil. Tidak ada perbedaan karakteristik dasar kelompok (usia, jenis kelamin dan diameter awal arteri brakhialis) yang signifikan 
diantara kedua kelompok. Respon dilatasi termediasi aliran secara signifikan menurun pada kelompok perokok pasif [8.7 (2.9) 
%] vs kelompok kontrol [12.8 (6.7) %] dengan p = 0.006. 
Kesimpulan. Merokok pasif berhubungan dengan penurunan fungsi dilatasi – tergantung endotel (endothelium-dependent 
dilatation), menimbulkan dugaan adanya proses aterosklerosis dini. 
(J Kardiol Indones. 2012;33:149-57)
Kata kunci: Merokok pasif, disfungsi endotel, vasodilatasi arteri brakhialis termediasi aliran
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Passive smoking or often called as secondhand 
smoke (SHS) or environmental tobacco smoke (ETS) 
is the inhalation of smoke from tobacco products used 
by others, which includes exposure to both sidestream 
smoke from burning cigarettes and exhaled mainstream 
smoke.2 Passive smoking increased the risk of heart 
disease by up to 30%, accounting for at least 35,000 
deaths annually in the United States.3
Endothelial dysfunction is an early feature of 
atherogenesis in vitro,4 in laboratory animals,5 and 
in humans.6 It represents an important marker 
of early vascular damage. Morphologic evidence 
of atherosclerosis can be detected as early as on 
second decade of life. Early detection on endothelial 
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dysfunction can hopefully prevents the subsequent 
atherosclerlotic events. 
Some factors had been associated with endothelial 
dysfunction severity on passive smokers, such as the 
number of hours of the exposure per day, the proximity 
to the active smokers, the number of active smokers 
at home of workplace, and the room ventilation size 
where inhalation takes place.1 We try to study one 
factor that may associates to the severity of endothelial 
dysfunction in passive smoking, which is the dose of 
exposure. In relation to dose-dependent, some previous 
studies found there were inverse relationships, while 
other studies found the contrary result. This might 
be due to the many parameters used, such as hours/
day, or just the number of years of exposure. Dose of 
environmental tobacco smoke exposure using hour-
years parameter which means the number of hours/
day multiply by the number or years of exposure has 
never been used before, and we assumed that this 
parameter will be more accurate to measure the dose 
of exposure.
 There’s been only a few studies assessed the 
effects of passive smoking to arterial wall in human.1 
Therefore, to gain data of the environmental tobacco 
smoke effects on healthy young adults, we assessed 
endothelial dysfunction in arteries of healthy young 
adults (mean age 25 years old) who had no known 
risk factors for atherosclerosis other than exposure 




We studied the subjects, who were eligible if they 
were 20 to 35 years of age, had normal blood 
pressure, did not have diabetes, and had no history of 
hyperlipidemia or family history of premature vascular 
diseases. They were clinically well and taking no 
regular cardiovascular medications. The subjects were 
chosen by a consecutive sampling, bordered by some 
period of time, and were matched in age and gender. 
Subjects were recruited from friends, families, hospital 
staff and other community volunteers. Subjects had 
to meet one of two groups criteria, control group or 
passive smoker group. Subjects in control group were 
nonsmokers who had never been regularly exposed to 
environmental tobacco smoke at home or workplace, 
while passive smokers group were nonsmokers with 
self-reported history of exposure to environmental 
tobacco smoke at least one hour per day for at least 
three years. All subjects gave informed consent, and 
the study was approved by the institutional committees 
on ethical practice. 
Study Design
This was a cross-sectional study. Each subject made 
one visit to the study hospital, which was also the time 
for medical history anamnesis, measurement of supine 
resting blood pressure, and the assessment of vascular 
reactivity of the brachial artery. 
Measurements and data analysis
The ultrasound method for measuring endothelium-
dependent arterial dilatation was measured in brachial 
artery, usingVivid 7® with 7.0 MHz linear array 
transducer. In this study, scans were obtained with 
the subject at rest, 1 minute and 2 minutes during 
reactive hyperemia. The brachial artery was scanned 
in cross-sectional section, 5 cm above the elbow, and 
the center of the artery was identified when the clearest 
picture of the anterior and posterior intimal layer was 
obtained.When a satisfactory transducer position was 
found, the skin was marked and the arm remained 
in the same position throughout the study.Increased 
flow was then induced by the inflation of a pneumatic 
torniquet placed around the forearm (distal to the 
scanned part of the artery) to a pressure 50 mmHg 
above subject’s systolic pressure, for 4 minutes and 30 
seconds. A second scan was performed at 60 seconds 
after deflation of the cuff, and the third was performed 
at 90 seconds.
The diameter of the vessel and flow-mediated 
vasodilatation responsewas measured by one observer, 
who was unaware of the subject status in groups. Then 
the cross-sectional boundaries of the artery were traced 
manually. This vasodilatation response was calculated 
as a percentage of change between maximum diameter 
of brachial artery reached before and after hyperemia 
reactive.
Statistical Analysis
Descriptive data for age and baseline brachial artery 
diameter were expressed as means + SD, and gender was 
expressed in percentage. An analysis for mean differences 
 
Jurnal Kardiologi Indonesia  
152 Jurnal Kardiologi Indonesia •  Vol. 33, No. 3 • Juli - September 2012
Table 1. Baseline Characteristics of Subjects
Characteristic Control Passive smokers Total P value
Subjects 48 32 80
Age (yr) 25,8 (4,6) 24,4 (3,4) 25,0 (4,0) 0,125




44 male (55 %)
36 female (45 %)
0,481
Brachialartery diameter at rest (mm) 3,3 (0,5) 3,5 (0,5) 3,4 (0,5) 0,200
Table 2. Vasodilatation response 
Characteristic Control Passive smokers P value
Average of vasodilatation response (%) 12,8 (6,7) 8,7 (2,9) 0,006
between passive smokers 3.5 (0.5) mm and in control 
subjects 3.3 (0.5) mm.
Vascular-Study Results
In response to reactive hyperemia, the average of 
vasodilatation response is 12,8 (6,7) percent in 
the control group. In the passive smokers group, 
the average ofvasodilatation responseis 8,7 (2,9) 
percent;which is significantly lower (p<0,006) for 
the comparison with the control group.
The range distribution of the vasodilatation 
response datain control group, is wider than the data 
in passive groups. The 95% CI for vasodilatation 
response in control groups are between 3-24%, whila 
in passive smoker groups are 5-15%. Then we can 
see the details in the box plot graph for analyze the 
descriptivecomparison between two groups, clearly, as 
in figure 1 below.
between two groups, based on important base-line 
characteristics, which were known could influence 
the FMD examination such as age, sex and baseline 
brachial artery diameter, were analyzed in Mannn-
whitney test and chi-square. Then the differences of 
vasodilation response within two group was analyzed 
by Mann-whitney test. Among the passive smokers, 
the relation between the dose of tobacco smoke’s 
exposure to vasodilatation response was assessed by 
Spearman correlation analysis. The determinant of 
vasodilatation response were then assessed by multipar 
linear regression analysis, with the vasodilatation 
response as the dependent variable, and age, sex, baseline 
diameter of brachial artery and duration on tobacco 
smoke’s exposure as the independent variables. Statistical 
significance was inferred at a two-tailed p value or less 




There are 80 subjects, consist of 44 males and 36 
females, which had an average age of 25.0 (4.0) years 
(range, 20-35). Passive smoking groups consist of 
32 subjects, 17 males (53.1%) and 15 females, with 
an average age 25.8 (4.6) years. In the 48 subjects as 
control group, 27 males (56.3 %) and 21 females, the 
average age was 24.4 (3.4) years old.This data shows 
that age and sex was similar in both groups (Table 1). 
Other important base-line characteristics – such as sex 
and vessel size at rest – were also similar in both groups.
Baseline brachial artery diameter was not different 
Figure 1. Data distribution of endothelium-dependent 





















Vasodilatation response in control and passive smoker group.
In each box plot. the bottom and top of box represent 25th percentile and the 75th percentile, respectively.
The line across each box represents the media value, and the vertical lines encompass the entire range of 
value for each group
 0.5 1.0 1.5 2.0 
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Among the 32 subjects in passive smoker group, 
although statistically insignificant, the dose of tobacco 
smoke’s exposure had a trendto inversely correlatedwith 
severity of endothelial dysfunction,which means that 
the higher the dose of tobacco smoke’s exposure, the 
lower vasodilatation response, as seen in the figure 2 
below.
Factors which influence the vasodilatation response 
among the passive smokers were then assessed by 
multiple variable linear regression analysis, with the 
vasodilatation response as dependent variable and age, 
sex, baseline diameter and dose of tobacco smoke’s 
exposure as independent variables. 
The analysis shows that the dose of tobacco smoke’s 
exposure is not an independent factor for the severity 
of endothelial dysfunction. The baseline brachial 
Figure 2. Relation between vasodilatation response of the 
brachial artery induced and the dose of tobacco smoke’s 
exposure
Table 3. Multiple variable linear regression analysis to vasodilatation response among the passive smoker group 
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artery diameter becomes the only determinant factor 
for the vasodilatation response in passive smoker (p = 
0,015), which means that the higher baseline brachial 
artery diameter, the lower vasodilatation response. 
Multiple linear regression equation for this data is : 
vasodilatation response = 16,440 – 2,243xbaseline 
brachial artery diameter (Table 3). 
That equation is a valid model for predictor 
of vasodilatation response (F value = 6,636; p = 
0,015) that can be seen in table 4. From the model 
summary, only 15,4% (adjusted R2 square = 0,154) 
of vasodilatation response (table 3) can be explained 
by this equation, and the rest are explained by other 
variables which not included in this study.
Discussion
Active cigarette smoking has long been known to 
predispose people to atherosclerotic vascular disease, 
but it has recently become evident that exposure to 
environmental tobacco smoke/passive smoking may 
also have deleterious cardiovascular effects, with 
enormous public health implications. This study 
shows that endothelial dysfunction, an important 
early feature of the atherogenic process, may occur in 
the systemic arteries of healthy young adults due to 
environmental tobacco smoke exposure. In this study 
we have shown that passive smokers have significantly 
impaired arterial endothelial function (p= 0.006). The 
mean vasodilatation response in passive smoker group 
was 8.7 (2.9) %, compared to 12.9 (6.7) % in control 
groups. This result wassimilar with previous study by 
Celermajer, which was 8.2 (3.1) % in control groups 
compared to 3.1 (2.7) % in passive smoker group.1 
Woo et al also found the differences in the subjects of 
passive smokers who were exposed to environmental 
tobacco smoke for over 8hours/day for at least two 
years to control group. The difference of mean and 
SD of diameter was 6.6 (3.4)% compared to 10.6 
(2.3) % in control group.7 Endothelium-dependent 
dilatation was significantly better in passive smoker 
groups 2.3 (2.1) % compared to control group 8.9 
(3.2) % in Raitakari studies, which had exposure to 
environmental tobacco smoke for 1 hours/day for > 2 
years as criteria for the passive smoker group.8 In study 
by Holay et al, FMD% was significantly higher in 
non-smokers than passive smokers 8.9 (4.8) compared 
to 5.0 (2.3) in control group.9However there was 
different results from study by Woo that showed36 
active or passive Chinese young adults smokers have 
less evidence of arterial dysfunction (7.3%) than the 
nonsmokers (7.9%) p>0.2.10 All of this data brought 
the fact that passive smoking have contribution to 
endothelial dysfunction formation. However, Woo 
et al was not exactly studied passive smoker group 
but His study compared young Chinese active and 
passive smokers who were matched in direct or indirect 
exposure with young Caucasians (England and Aussie), 
so the results were not as specific as other studies.
But because our study examined the effects of 
passive smoking cessation on arterial reactivity in a 
cross sectional setting, the result should interpreted 
with caution. A more ideal approach would be serial 
prospective study of persons.
Self-reporting of exposure to environmental 
tobacco smoke by questionnaire was used because no 
methods are available to objectively quantify previous 
exposure to tobacco smoke.
The actual mechanism responsible for this arterial 
damage is not known, but might be related to the 
effects of tobacco smoke by interactions between 
platelets and vessel wall or by alteration of oxidation 
products or lipid components due to long-term 
environmental tobacco smoke exposure.11
Environmental tobacco smoke consists of approxi-
mately 85 percent sidestream smoke (from the burning 
ends of cigarettes) and 15 percent exhaled mainstream 
Table 4. Analysis of Variance for the predictor of baseline brachial artery diameter to vasodilatation 
response
Model Sum of Squares df Mean Square F Sig.
7 Regression 46.692 1 46.692 6.636 .015(g)
Residual 211.081 30 7.036
Total 257.774 31
Predictors: (Constant), baseline diameter
Dependent Variable: vasodilatation response
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smoke.12 Since cigarettes burn at higher temperatures 
during inhalation, combustion is more complete, and 
some toxic components, such as carbon monoxide 
and benzopyrene, are found in higher concentrations 
in sidestream than in inhaled smoke.13 Moreover, 
there are as many as 4000 chemicals are contained in 
environmental tobacco smoke.12
Environmental tobacco smoke in both low and 
high dose, increases the percentage of the aorta covered 
by atheroma in cholesterol-fed rabbits.14 It also expose 
cockerels to levels of environmental tobacco smoke 
routinely encountered by people in smoke-filled 
environments is associated with the increasing size 
of aortic atheroma plaques.15 Sun et alhave shown 
that dietary supplementation with L-arginine (the 
precursor of nitrit oxide, or endothelium-derived 
relaxing factor) protects cholesterol-fed rabbits from 
the endothelial dysfunction associated with exposure 
to environmental tobacco smoke. This finding suggests 
impaired endothelial production of nitrit oxide might 
be pathogenetically important in environmental 
tobacco smoke-related atherosclerosis of this animal 
model.16
Impaired bioavailability of nitrit oxide as 
endothelium-derived relaxing factor, may be 
particularly important, since nitrit oxide acts to 
inhibit platelet aggregation, adhesion of monocytes to 
the arterial wall, and proliferation of smooth-muscle 
cells. Dilatation mediated by brachial-artery flow is 
endothelium-dependent and is mediated in large part 
by the release of nitrit oxide. Therefore, our result 
suggest that the activity of endothelial nitrit oxide 
may be impaired in young passive smokers as well as 
in active smokers.17 Passive smoking-related arterial 
damage may also be the consequence of enhanced 
degradation of nitrit oxide secondary to formation 
of oxygen-derived free radicals.18
Because we studied healthy young adults without 
known atherogenic risk factors, such as diabetes 
or hypertension, which have been shown to cause 
impaired vascular reactivity, we were able to investigate 
the effects of passive smoking alone on endothelial 
physiology.19 Although only superficial systemic arteries 
can be studied with this ultrasound-based method, 
endothelial dysfunction in the brachial artery appears 
to be well correlated with both coronary endothelial 
physiology20 and coronary atherosclerosis.21
This data could support individual and public 
health policy initiatives to allow nonsmokers to 
avoid smoke-filled environments at home or in the 
workplace.All the passive smokers in this study were 
exposed to environmental tobacco smoke for at least 
one hour per day. Unexpectedly, the result of this study 
shows that there are no significant dose-dependent 
relationship between exposure to tobacco smoke to 
the severity of endothelial dysfunction (r = - 0.239. 
p=0.187). Contrary to Celermajer study that showed 
FMD was inversely related to the intensity of exposure 
(r = -0.39, p=0.04).1The study use exposure in hours/
day on subjects that were divided into three groups, 
light (exposure 1-3 hrs/day), moderate (4-6 hrs/day) 
an heavy (more than 6 hrs/day).1
In He et al22 meta-analytic studies, the relative 
risk of coronary heart disease increased significantly 
with exposure to a higher level or a longer duration 
of passive smoking. Compared to non-smokers who 
were not exposed to smoke, non smokers who were 
exposed to 1 to 19 cigarettes per day and to 20 or more 
cigarettes per day had relative risks of coronary heart 
disease of 1.23 (95% CI, 1.13-1.34) and 1.31 (95% 
CI, 1.21-1.42), respectively (p = 0.006). Likewise, as 
compared with nonsmokers who were not exposed to 
cigarette smoke, non smokers who were exposed to the 
spouse’s smoke for 1 to 9 years, 10 to 19 years, and 
20 or more years had relative risks of coronary heart 
disease of 1.18 (95% CI 0.98-1.42), 1.31 (95% CI 
1.11-1.55) and 1.29 (95% CI 1.16-1.43), respectively 
(p=0.01 for linear trend). This study showed a 
significant result when compared to non-smokers, but 
the relative risk shows smaller trends after some degree 
of exposure. Negative trends also found in groups with 
the exposure > 20 years.22
This study uses a new parameter, hours-years, of 
which hours/day of exposure multiplies with years 
of exposure. With this new parameter, we expect to 
get more accurate result on the relation between the 
doseof tobacco smoke’s exposure with the severity 
of endothelial dysfunction. This study showed there 
was an inverse trend, that the bigger and the longer 
amount of exposure, the lower vasodilatation response 
with FMD in brachial artery. However this finding 
was not significant. This might happened due to 
the homogenity of the passive smokersubjects that 
distribute in “low dose” passive smoking, or maybe 
it is true that there is no dose dependent in this 
relationship.
It leads to an interesting question of what can act 
as a cause. The alteration of gene transcription in nitrit 
oxide synthetase or alteration related to endothelial 
progenitor cells are assumed as the underlying 
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mechanism. However, further study is required to 
intensively learn about the dose dependent which 
related to the severity. The study should also control 
confounding factors, such as proximity to the smokers, 
ventilationof the room where the exposure takes place, 
the number of cigarettes, etc. Further study also 
required to find at what level of the exposure does 
endothelial dysfunction begins to develop, and the 
reversibility. 
In the determination of flow-mediated dilatation 
among passive smokers assessed by multivariable 
regression analysis, baseline brachial artery diameter 
becomes the only independent variables as predictor 
for the vasodilatation response. This is similar to study 
by Ryliskite,that found FMD in low cardiovascular risk 
patient inversely correlates with age as well as brachial 
artery diameter.Age was not an independent factor in 
the study, which might be due to the narrow range of 
the age.23
Limitation
In this study, there were some uncontrolled factors that 
can impede the result of FMD examination such as 
menstrual phase from female subjects, homocysteine 
blood level and birth weight. However, the menstrual 
phase should not confound the study because the 
two groups were gender matches. Differential analysis 
according to gender are probably not worthwhile 
considering small numbers of subjects studied.Data 
on traditional cardiovascular risk factors were not 
objective as they were only based on subject’s history 
and physical examination. But then again since all 
subjects were young and clinically healthy, this also 
should not be considered as a confounding factor. 
In the present study, passive smoking was identified 
and assessed by self-reporting data using structured 
questionnaire, which we have previously shown to 
be reliable. Ideally, the concentrations of nicotine/
cotinine in the body should be measured since there 
were positive associations between self-reported and/
or objective measures of secondhand tobacco smoke 
exposure.24But study by Steenland, stated that serum 
cotinine only reflects recent ETS exposure, and also 
showed that there will only be a low heart disease risk 
factors when ETS exposure is determined by self-
reported data.25
There has been difficulty in quantifying the “dose” 
of passive smoking with certainty, as the intensity of 
exposure depends on a large number of variables, such 
as hours of exposure per day, the proximity to active 
smokers, the number of active smokers in the room, 
and the size and ventilation of the rooms where passive 
smoking takes place.1 But because that was not the 
main objective of this study, the data was not obtained. 
But for further study ahead, those data should be 
collected to sharpen the result and the study should 
also be analyzed using multivariate analysis to find 
which variableis more likely related to the severity of 
endothelial dysfunction in passive smoker.
Conclusion
Passive smoking is associated with significant 
impairment of endothelial function in healthy 
young adults, independent of age, gender and 
baseline brachial artery diameter, and traditional risk 
parameters. There was no dose-dependent relationship 
between hours-years of exposure parameters to severity 
of endothelial dysfunction. This means, even short 
term and regularly exposure of smoking can impact 
to a damaged in arterial wall. This result hopefully can 
strengthen government effort on campaignsof smoking 
ban in public area. To achieve a significant reduction of 
society burden on coronary heart disease, both passive 
and active cigarette smoking must be considered. 
Clinicians should inform their patients about all risks 
associated with passive smoking and also suggestion 
to give all support to enforcement of smoking bans in 
all public areas. 
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